Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Arévalo-Martı́n Á[au]:

Spicing Up Pharmacology: A Review of Synthetic Cannabinoids From Structure to Adverse Events. Davidson C et al. Adv Pharmacol. (2017)

Cannabinoids to treat spinal cord injury. Arevalo-Martin A et al. Prog Neuropsychopharmacol Biol Psychiatry. (2016)

Wnts Are Expressed in the Ependymal Region of the Adult Spinal Cord. Gonzalez-Fernandez C et al. Mol Neurobiol. (2017)

Search results

Items: 33

1.

Elevated Autoantibodies in Subacute Human Spinal Cord Injury Are Naturally Occurring Antibodies.

Arevalo-Martin A, Grassner L, Garcia-Ovejero D, Paniagua-Torija B, Barroso-Garcia G, Arandilla AG, Mach O, Turrero A, Vargas E, Alcobendas M, Rosell C, Alcaraz MA, Ceruelo S, Casado R, Talavera F, Palazón R, Sanchez-Blanco N, Maier D, Esclarin A, Molina-Holgado E.

Front Immunol. 2018 Oct 11;9:2365. doi: 10.3389/fimmu.2018.02365. eCollection 2018.

2.

Cells in the adult human spinal cord ependymal region do not proliferate after injury.

Paniagua-Torija B, Norenberg M, Arevalo-Martin A, Carballosa-Gautam MM, Campos-Martin Y, Molina-Holgado E, Garcia-Ovejero D.

J Pathol. 2018 Dec;246(4):415-421. doi: 10.1002/path.5151. Epub 2018 Oct 30.

PMID:
30091291
3.

Laser-Capture Microdissection for the Analysis of Rat and Human Spinal Cord Ependyma by qPCR.

Garcia-Ovejero D, Paniagua-Torija B, Arevalo-Martin A, Navarro-Galve B, Molina-Holgado E.

Methods Mol Biol. 2018;1723:285-318. doi: 10.1007/978-1-4939-7558-7_17.

PMID:
29344868
4.

Spicing Up Pharmacology: A Review of Synthetic Cannabinoids From Structure to Adverse Events.

Davidson C, Opacka-Juffry J, Arevalo-Martin A, Garcia-Ovejero D, Molina-Holgado E, Molina-Holgado F.

Adv Pharmacol. 2017;80:135-168. doi: 10.1016/bs.apha.2017.05.001. Epub 2017 Jun 20. Review.

PMID:
28826533
5.

Wnts Are Expressed in the Ependymal Region of the Adult Spinal Cord.

Gonzalez-Fernandez C, Arevalo-Martin A, Paniagua-Torija B, Ferrer I, Rodriguez FJ, Garcia-Ovejero D.

Mol Neurobiol. 2017 Oct;54(8):6342-6355. doi: 10.1007/s12035-016-0132-8. Epub 2016 Oct 8.

PMID:
27722925
6.

CB1 cannabinoid receptor enrichment in the ependymal region of the adult human spinal cord.

Paniagua-Torija B, Arevalo-Martin A, Ferrer I, Molina-Holgado E, Garcia-Ovejero D.

Sci Rep. 2015 Dec 4;5:17745. doi: 10.1038/srep17745.

7.

The ependymal region of the adult human spinal cord differs from other species and shows ependymoma-like features.

Garcia-Ovejero D, Arevalo-Martin A, Paniagua-Torija B, Florensa-Vila J, Ferrer I, Grassner L, Molina-Holgado E.

Brain. 2015 Jun;138(Pt 6):1583-97. doi: 10.1093/brain/awv089. Epub 2015 Apr 15.

8.

Cannabinoids to treat spinal cord injury.

Arevalo-Martin A, Molina-Holgado E, Garcia-Ovejero D.

Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:190-9. doi: 10.1016/j.pnpbp.2015.03.008. Epub 2015 Mar 21. Review.

PMID:
25805333
9.

Spinal cord injury induces a long-lasting upregulation of interleukin-1β in astrocytes around the central canal.

Paniagua-Torija B, Arevalo-Martin A, Molina-Holgado E, Molina-Holgado F, Garcia-Ovejero D.

Neuroscience. 2015 Jan 22;284:283-9. doi: 10.1016/j.neuroscience.2014.10.013. Epub 2014 Oct 19.

PMID:
25453765
10.

Neuroimmmune interactions of cannabinoids in neurogenesis: focus on interleukin-1β (IL-1β) signalling.

García-Ovejero D, Arévalo-Martín Á, Navarro-Galve B, Pinteaux E, Molina-Holgado E, Molina-Holgado F.

Biochem Soc Trans. 2013 Dec;41(6):1577-82. doi: 10.1042/BST20130198. Review.

PMID:
24256257
11.

Early endogenous activation of CB1 and CB2 receptors after spinal cord injury is a protective response involved in spontaneous recovery.

Arevalo-Martin A, Garcia-Ovejero D, Sierra-Palomares Y, Paniagua-Torija B, Gonzalez-Gil I, Ortega-Gutierrez S, Molina-Holgado E.

PLoS One. 2012;7(11):e49057. doi: 10.1371/journal.pone.0049057. Epub 2012 Nov 13.

12.

A cell population that strongly expresses the CB1 cannabinoid receptor in the ependyma of the rat spinal cord.

Garcia-Ovejero D, Arevalo-Martin A, Paniagua-Torija B, Sierra-Palomares Y, Molina-Holgado E.

J Comp Neurol. 2013 Jan 1;521(1):233-51. doi: 10.1002/cne.23184.

PMID:
22791629
13.

A CB₁/CB₂ receptor agonist, WIN 55,212-2, exerts its therapeutic effect in a viral autoimmune model of multiple sclerosis by restoring self-tolerance to myelin.

Arevalo-Martin A, Molina-Holgado E, Guaza C.

Neuropharmacology. 2012 Sep;63(3):385-93. doi: 10.1016/j.neuropharm.2012.04.012. Epub 2012 Apr 27.

PMID:
22561283
14.

CB1 receptor antagonism/inverse agonism increases motor system excitability in humans.

Oliviero A, Arevalo-Martin A, Rotondi M, García-Ovejero D, Mordillo-Mateos L, Lozano-Sicilia A, Panyavin I, Chiovato L, Aguilar J, Foffani G, Di Lazzaro V, Molina-Holgado E.

Eur Neuropsychopharmacol. 2012 Jan;22(1):27-35. doi: 10.1016/j.euroneuro.2011.04.004. Epub 2011 May 14.

PMID:
21571507
15.

The constitutive production of the endocannabinoid 2-arachidonoylglycerol participates in oligodendrocyte differentiation.

Gomez O, Arevalo-Martin A, Garcia-Ovejero D, Ortega-Gutierrez S, Cisneros JA, Almazan G, Sánchez-Rodriguez MA, Molina-Holgado F, Molina-Holgado E.

Glia. 2010 Dec;58(16):1913-27. doi: 10.1002/glia.21061.

PMID:
20878765
16.

The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury.

Arevalo-Martin A, Garcia-Ovejero D, Molina-Holgado E.

Neurobiol Dis. 2010 May;38(2):304-12. doi: 10.1016/j.nbd.2010.02.002. Epub 2010 Feb 13.

PMID:
20156559
17.

The endocannabinoid system is modulated in response to spinal cord injury in rats.

Garcia-Ovejero D, Arevalo-Martin A, Petrosino S, Docagne F, Hagen C, Bisogno T, Watanabe M, Guaza C, Di Marzo V, Molina-Holgado E.

Neurobiol Dis. 2009 Jan;33(1):57-71. doi: 10.1016/j.nbd.2008.09.015. Epub 2008 Sep 30.

PMID:
18930143
18.

The endocannabinoid system modulates a transient TNF pathway that induces neural stem cell proliferation.

Rubio-Araiz A, Arévalo-Martín A, Gómez-Torres O, Navarro-Galve B, García-Ovejero D, Suetterlin P, Sánchez-Heras E, Molina-Holgado E, Molina-Holgado F.

Mol Cell Neurosci. 2008 Jul;38(3):374-80. doi: 10.1016/j.mcn.2008.03.010. Epub 2008 Apr 10.

PMID:
18499473
19.

CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies.

Arévalo-Martín A, García-Ovejero D, Gómez O, Rubio-Araiz A, Navarro-Galve B, Guaza C, Molina-Holgado E, Molina-Holgado F.

Br J Pharmacol. 2008 Jan;153(2):216-25. Epub 2007 Sep 24. Review.

20.

Cannabinoids modulate Olig2 and polysialylated neural cell adhesion molecule expression in the subventricular zone of post-natal rats through cannabinoid receptor 1 and cannabinoid receptor 2.

Arévalo-Martín A, García-Ovejero D, Rubio-Araiz A, Gómez O, Molina-Holgado F, Molina-Holgado E.

Eur J Neurosci. 2007 Sep;26(6):1548-59.

PMID:
17880390
21.

CB2 cannabinoid receptors promote mouse neural stem cell proliferation.

Molina-Holgado F, Rubio-Araiz A, García-Ovejero D, Williams RJ, Moore JD, Arévalo-Martín A, Gómez-Torres O, Molina-Holgado E.

Eur J Neurosci. 2007 Feb;25(3):629-34.

PMID:
17328768
22.

[Cannabinoid system and neuroinflammation:therapeutic perspectives in multiple sclerosis].

Mestre L, Correa F, Docagne F, Clemente D, Ortega-Gutiérrez S, Arévalo-Martín A, Molina-Holgado E, Borrell J, Guaza C.

Rev Neurol. 2006 Nov 1-15;43(9):541-8. Review. Spanish.

23.

The role of cannabinoid system on immune modulation: therapeutic implications on CNS inflammation.

Correa F, Mestre L, Molina-Holgado E, Arévalo-Martín A, Docagne F, Romero E, Molina-Holgado F, Borrell J, Guaza C.

Mini Rev Med Chem. 2005 Jul;5(7):671-5. Review.

PMID:
16026313
24.

Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis.

Ortega-Gutiérrez S, Molina-Holgado E, Arévalo-Martín A, Correa F, Viso A, López-Rodríguez ML, Di Marzo V, Guaza C.

FASEB J. 2005 Aug;19(10):1338-40. Epub 2005 Jun 7.

PMID:
15941768
25.

Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis.

Mestre L, Correa F, Arévalo-Martín A, Molina-Holgado E, Valenti M, Ortar G, Di Marzo V, Guaza C.

J Neurochem. 2005 Mar;92(6):1327-39.

26.

Therapeutic action of cannabinoids in a murine model of multiple sclerosis.

Arévalo-Martín A, Vela JM, Molina-Holgado E, Borrell J, Guaza C.

J Neurosci. 2003 Apr 1;23(7):2511-6.

27.

[Theiler's virus encephalomyelitis infection as a model for multiple sclerosis: cytokines and pathogenic mechanisms].

Molina-Holgado E, Areválo-Martín A, Vela JM, Guaza C.

Rev Neurol. 2002 Nov 16-30;35(10):973-8. Review. Spanish.

28.

Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling.

Molina-Holgado E, Vela JM, Arévalo-Martín A, Almazán G, Molina-Holgado F, Borrell J, Guaza C.

J Neurosci. 2002 Nov 15;22(22):9742-53.

29.

Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells.

Vela JM, Molina-Holgado E, Arévalo-Martín A, Almazán G, Guaza C.

Mol Cell Neurosci. 2002 Jul;20(3):489-502.

PMID:
12139924
30.

Interleukin-4 and interleukin-10 modulate nuclear factor kappaB activity and nitric oxide synthase-2 expression in Theiler's virus-infected brain astrocytes.

Molina-Holgado E, Arévalo-Martín A, Castrillo A, Boscá L, Vela JM, Guaza C.

J Neurochem. 2002 Jun;81(6):1242-52.

31.
32.

Prenatal immune challenge disrupts sensorimotor gating in adult rats. Implications for the etiopathogenesis of schizophrenia.

Borrell J, Vela JM, Arévalo-Martin A, Molina-Holgado E, Guaza C.

Neuropsychopharmacology. 2002 Feb;26(2):204-15.

33.

LPS/IFN-gamma cytotoxicity in oligodendroglial cells: role of nitric oxide and protection by the anti-inflammatory cytokine IL-10.

Molina-Holgado E, Vela JM, Arévalo-Martín A, Guaza C.

Eur J Neurosci. 2001 Feb;13(3):493-502.

PMID:
11168556

Supplemental Content

Loading ...
Support Center